Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues

被引:146
|
作者
Nagaoka, I
Hirota, S
Niyonsaba, F
Hirata, M
Adachi, Y
Tamura, H
Tanaka, S
Heumann, D
机构
[1] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan
[2] Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Sch Pharm, Tokyo, Japan
[3] Seikagaku Corp, Cent Res Labs, Tokyo, Japan
[4] Ctr Hosp Univ Vaudois Lausanne, Div Infect Dis, Lausanne, Switzerland
关键词
D O I
10.1128/CDLI.9.5.972-982.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mammalian myeloid and epithelial cells express various peptide antibiotics (such as defensins and cathelicidins) that contribute to the innate host defense against invading microorganisms. Among these peptides, human cathelicidin CAP18/LL-37 (L-1 to S-37) possesses not only potent antibacterial activity against gram-positive and gram-negative bacteria but also the ability to bind to gram-negative lipopolysaccharide (LPS) and neutralize its biological activities. In this study, to develop peptide derivatives with improved LPS-neutralizing activities, we utilized an 18-mer peptide (K-15; to V-32) of LL-37 as a template and evaluated the activities of modified peptides by using the CD14(+) murine macrophage cell line RAW 264.7 and the murine endotoxin shock model. By replacement of E-16 and K-25 With two L residues, the hydrophobicity of the peptide (18-mer LL) was increased, and by further replacement of Q(22), D-26, and N-30 with three K residues, the cationicity of the peptide (18-mer LLKKK) was enhanced. Among peptide derivatives, 18-mer LLKKK displayed the most powerful LPS- neutralizing activity: it was most potent at binding to LPS, inhibiting the interaction between LPS and LPS-binding protein, and attaching to the CD14 molecule, thereby suppressing the binding of LPS to CD14(+) cells and attenuating production of tumor necrosis factor alpha (TNF-alpha) by these cells. Furthermore, in the murine endotoxin shock model, 18-mer LLKKK most effectively suppressed LPS-induced TNF-alpha production and protected mice from lethal endotoxin shock. Together, these observations indicate that the LPS-neutralizing activities of the amphipathic human CAP18LL-37-derived 18-mer peptide can be augmented by modifying its hydrophobicity and cationicity, and that 18-mer LLKKK is the most potent of the peptide derivatives, with therapeutic potential for gram-negative bacterial endotoxin shock.
引用
收藏
页码:972 / 982
页数:11
相关论文
共 5 条
  • [1] Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions
    Nagaoka, I
    Kuwahara-Arai, K
    Tamura, H
    Hiramatsu, K
    Hirata, M
    INFLAMMATION RESEARCH, 2005, 54 (02) : 66 - 73
  • [2] Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions
    I. Nagaoka
    K. Kuwahara-Arai
    H. Tamura
    K. Hiramatsu
    M. Hirata
    Inflammation Research, 2005, 54 : 66 - 73
  • [3] Development of Human Cathelicidin LL-37-derived Short Antimicrobial Peptides with Prokaryotic Selectivity, LPS-neutralizing Activity and Protease Stability
    Shin, S. Y.
    Nan, Y. H.
    Bang, J. K.
    JOURNAL OF PEPTIDE SCIENCE, 2012, 18 : S61 - S61
  • [4] Augmentation of the antimicrobial activities of guinea pig cathelicidin CAP11-derived peptides by amino acid substitutions
    Okuda, Daiju
    Yomogida, Shin
    Kuwahara-Arai, Kyoko
    Hitamatsu, Keiichi
    Tamura, Hiroshi
    Nagaoka, Isao
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (04) : 501 - 508
  • [5] An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7
    Nagaoka, Isao
    Tamura, Hiroshi
    Hirata, Michimasa
    JOURNAL OF IMMUNOLOGY, 2006, 176 (05): : 3044 - 3052